Cite
HARVARD Citation
Davis, E. et al. (2018). A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers. American journal of clinical oncology. p. . [Online].